ClinicalTrials.gg
Not yet recruitingNCT07911436Updated Nov 2, 2026

Virtual Reality to Reduce Anxiety During Thoracic Epidural Placement.

An interventional study of VR- headset in Preoperative Anxiety Score, sponsored by Universitaire Ziekenhuizen KU Leuven. Not yet recruiting. Open to participants aged 13 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Prevention

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
13 Years to 19 Years
Sex
All
01

Study summary

The purpose of this study is to investigate whether using a Virtual Reality (VR) headset can help young people relax during the placement of an epidural catheter for pain control after pectus surgery.

An epidural catheter is a thin tube that is inserted by the anesthesiologist between two vertebrae in the back. Many teenagers experience anxiety or stress during the placement of this catheter.

To help reduce anxiety, medication called Midazolam can be given through an IV line. However, this does not always provide enough relief. Scientific studies have shown that virtual reality (VR) can help reduce anxiety, stress, and pain during medical procedures. By focusing on a virtual environment, patients are less aware of the procedure itself. In particular, VR has been shown to be a safe and effective way of improving comfort for children and adolescents during medical examinations and treatments.

A total of 78 adolescents aged 13 to 19 years will participate in this study. Participants will be randomly assigned to one of two groups, each consisting of 39 participants:

Children in the interventional group will wear a VR headset during the placement of the epidural catheter. If the child still experiences significant anxiety or stress during the procedure, Midazolam will be administered through the IV line.

Children assigned to the control group will receive the usual care. This means that Midazolam will be given through the IV line if your child experiences significant anxiety or stress. Children in this group will not receive a VR headset.

02

Conditions studied

  • Preoperative Anxiety Score

Keywords

  • Epidural katheter
  • Preoperative anxiety
  • virtual reality
03

In context

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 963 studies on the registry; 267 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntary written informed assent of the minor participant + consent of their legally authorized representative or voluntary written of the adult participant has been obtained prior to any screening procedures
  • Between 13 \& 19 years of age at the time of signing the Informed Consent Form (ICF)
  • Scheduled for elective Pectus Excavatum or Carinatum repair (Nuss/Ravitch) with planned Thoracic Epidural Analgesia (TEA).
  • Proficiency in Dutch to allow self-assessment via VAS-Anxiety

Exclusion criteria

Exclusion Criteria:

  • Patient has history of Epilepsy or Seizure Disorder
  • Regular use of anxiolytics, sedatives, or psychoactive medication at home.
  • Deafness or blindness preventing VR engagement or VAS self-assessment.
  • Known to TEA (e.g., coagulopathy) or refusal of TEA.
  • Urgent or emergency surgery.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
78 participants (estimated)

Study arms

  • No intervention
    Control group

    Children will receive the usual care.

  • Experimental
    Interventional group

    Children will wear a Virtual Reality headset during the placement of the epidural catheter.

    Device: VR- headset

Interventions

  • DeviceVR- headset

    Children will wear a VR headset during the placement of the epidural catheter.

06

What researchers measure

Primary outcomes

  1. Postprocedural anxiety score

    Subjective Anxiety/stress measured by the VAS from 0 (no anxiety/distress) and 100mm (extreme anxiety/distress)

    Time frame: postprocedural until 10 min after procedure

Secondary outcomes

  1. anxiety assessments by the physician performing the epidural, the assisting nurse and accompanying parent, reflecting their perception of the patient's anxiety (NRS)

    measured by the VAS from 0 (no anxiety/distress) and 100mm (extreme anxiety/distress)

    Time frame: 10 min preprocedural

  2. anxiety questionnaire from the patient

    anxiety questionnaire from the patient

    Time frame: 10 min preprocedural

  3. - Rescue sedation medication during placement of the epidural catheter

    dose of Midazolam in mg

    Time frame: during the procedure

  4. - Efficacy of epidural placement:

    Time and number of attempts

    Time frame: during the procedure

  5. patient satisfaction score

    NRS: from 0-10, 0=not satisfied and 10=very satisfied

    Time frame: postprocedural until 10 min after procedure

  6. - Pain score of placement of the epidural catheter

    NRS from 0-10, 0=no pain and 10=worst pain)

    Time frame: postprocedural until 10 min after procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07911436
Responsible party
Sponsor
First posted
Nov 2, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Nov 2, 2026

Study contacts

Geertrui Dewinter, Phd, MD
Contact
geertrui.dewinter@uzleuven.be
+32 16 34 4270

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion